Cephradine, a new semisynthetic cephalosporin derivative, is 7[D(-)-2-amino-2-(1 ,4-cyclohexadien-1-yl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate. The compound has a broad spectrum of antimicrobial activity in vitro. When given subcutaneously to mice, cephradine was appreciably more effective than cephalothin against infections induced by penicillinase-producing Staphylococcus, Escherichia coli, Klebsiella pneumoniae, or Enterobacter cloacae strains. Cephradine and cephaloridine possessed equivalent activity in treating infections caused by these same three gram-negative bacteria. The mean total bioactivity of cephradine in the serum of mice peaked within 30 min (59 ug/ml) after parenteral administration and was approximately threefold that of cephalothin (20 pg/ml), but less than that of cephaloridine (83 ug/ml). Nearly all of the administered cephradine (84%) and cephaloridine (70%) were excreted in the urine as the parent compounds. In contrast, only 47% (total bioactivity) of administered cephalothin was recovered, an amount that represented only 15 to 20% of the parent substance.
The semisynthetic cephalosporins have become of considerable interest to clinicians, who are prescribing these antibiotics widely. The broad spectrum of antibacterial activity demonstrated by these antibiotics and their resistailce to degradation by penicillinases have made them particularly well accepted. A new member of this group, cephradine, is [7-D(-)-2-amino-2-(1, 4-cyclohexadien-1-yl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrite (1) . Previous studies (H. H. Gadebusch et al., Progr. Antimicrob. Anticailcer Chemother., in press) had shown that cephradine possessed a broad spectrum of antibacterial activity, was bactericidal to susceptible organisms, and was resistant to degradation over a wide pH range. In model bacterial infections in mice, cephradine was effective when given either orally or parenterally.
The present studies sought to compare concentrations of cephradine in serum, its renal excretion, its metabolism, and its chemotherapeutic efficacy witk those of two other cephalosporin antibiotics. To determine the level of bioactivity in the serum, mice were bled from the retroorbital sinus at 0.5, 1, and 3 hr after dosing. The serum, representing a pool from three mice for each dose level of antibiotic injected, was immediately separated from the whole blood by centrifugation and was stored at 4 C.
To determine the level of bioactivity in the urine, the total urinary output for six mice in the 6-hr period after dosing was collected in tubes packed in Dry Ice. Both sera and urine were tested for bioactivity on the day of collection by a disc diffusion assay, with Sarcina lutea SC 2495 as the test organism. Appropriate samples of urine were retained for metabolic studies.
Metabolic studies. Urine samples from mice given cephradine, cephalothin, or cephaloridine, as well as control samples of cephradine, cephalothin, desacetylcephalothin (a known metabolite of cephalothin), and cephaloridine dissolved in urine, were applied to Whatman no. 1 paper that had been impregnated with potassium citrate buffer at pH 4.5. Samples containing cephalothin, desacetylcephalothin, or cephaloridine were developed in acetone-water (9:1); samples containing cephradine were developed in acetone-water (3:1). After development, the paper chromatograms were scanned under ultraviolet light and bioautographed on agar plates that had been seeded with S. lutea SC 2495.
Minimal inhibitory concentration (MIC). Twofold broth dilution tests were used to determine the susceptibility of the selected test organisms to the title compounds.
Statistics. The statistical formula for estimation of the 95% confidence limits of the geometric means was adapted from J. Ciminera, as reported by Miller et al. (5) . RESULTS
Based on the chemotherapeutic activities, cephradine, in addition to being more effective than cephalothin against both a penicillinsusceptible and a penicillin-resistant Staphylococcus strain, was also more active than cephalothin in the treatment of infections caused by gramnegative bacteria, as represented by Escherichia coli SC 8294, Klebsiella pneumoniae SC 8340, and Enterobacter cloacae SC 8236 (Table 1) .
The MIC of cephradine against S. aureus SC 2399, for example, was 3.1 ug/ml. The activity of cephalothin in vitro was approximately 30 times greater than this, yet cephradine was substantially more active in vivo than was cephalothin. The same general trend obtains for S. aureus SC 2400, for E. coli SC 8294, and for K. pneumoniae SC 8340.
In contrast, cephradine and cephaloridine showed equivalent activities in mice challenged with the three gram-negative bacteria tested (Table 1) . Against gram-positive organisms, however, cephaloridine was the most active of the three cephalosporins examined.
Measurement of the total bioactivity in the serum of mice given a dose of 100 mg of cephradine per kg subcutaneously showed a mean peak concentration of 59 ,ug/ml in 30 min, a level three times higher than that in mice given a comparable dose of cephalothin (Fig. 1) . One hour after dosing, the concentration of cephradine in the serum was 9.7 ,ug/ml, compared with a concentration of 1.3 ,ug/ml for total bioactivity in mice treated with cephalothin. Bioactivity in the serum of mice treated with cephaloridine (83 ,ug/ml) was slightly higher than that in mice treated with cephradine. By the third hour after dosing, however, all test compounds yielded serum levels less than 1 ,ug/ml.
In the urine, the total bioactivities of the three cephalosporins were dose-related and were highest for cephradine. When bioactivity in the urine was expressed in micrograms per milliliter, the value for cephaloridine was higher than that for cephradine. This difference, however, was more apparent than real, for the mean volume of urine excreted by the mice given cephaloridine (2.0 ml) was significantly less than that excreted by mice given cephradine (2.9 ml).
As judged by chromatographic analysis and bioactivity in the urine ( (4) .
